Jill P Buyon Selected Research

Jill P Buyon Research Topics

Disease

47	Congenital heart block 10/2020 - 01/2002
40	Neonatal Systemic lupus erythematosus 06/2022 - 01/2002
40	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2002
18	Inflammation (Inflammations) 01/2019 - 06/2002
14	Cicatrix (Scar) 11/2017 - 01/2003
13	Fibrosis (Cirrhosis) 09/2017 - 08/2002
11	Lupus Nephritis 01/2022 - 07/2005
7	Nephritis 01/2021 - 07/2005
7	Heart Block 02/2016 - 08/2005
6	Exanthema (Rash) 01/2022 - 09/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2003
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 10/2010
5	Heart Diseases (Heart Disease) 01/2020 - 10/2009
4	COVID-19 08/2021 - 01/2020
3	Rheumatic Diseases (Rheumatism) 07/2021 - 09/2002
3	Thrombosis (Thrombus) 07/2021 - 06/2005
3	Cardiomyopathies (Cardiomyopathy) 11/2014 - 08/2010
2	Atrioventricular Block 06/2022 - 07/2012
2	Cardiotoxicity 10/2020 - 09/2017
2	Pre-Eclampsia (Preeclampsia) 01/2019 - 01/2009
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017 - 08/2004
2	Disease Progression 01/2016 - 01/2016
2	Hypertension (High Blood Pressure) 01/2016 - 01/2009
2	Vascular System Injuries 07/2005 - 02/2005
1	Reinfection 08/2021
1	Toxic Optic Neuropathy 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Atherosclerosis 01/2019
1	Albuminuria 01/2018
1	Myocardial Infarction 01/2018
1	Ischemic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

41	AntibodiesIBA 06/2022 - 01/2002
38	AutoantibodiesIBA 01/2021 - 01/2002
14	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
12	SS-A antibodiesIBA 01/2022 - 12/2007
10	AntigensIBA 01/2021 - 01/2003
9	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2010
8	Immunoglobulin G (IgG)IBA 08/2021 - 01/2002
7	RibonucleoproteinsIBA 09/2017 - 10/2003
7	Dexamethasone (Maxidex)FDA LinkGeneric 09/2012 - 06/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2004
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 10/2010
5	Proteins (Proteins, Gene)FDA Link 06/2017 - 12/2007
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2007 - 09/2003
4	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2010
4	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2016 - 06/2005
4	Urokinase Plasminogen Activator ReceptorsIBA 08/2015 - 08/2010
4	CytokinesIBA 08/2004 - 02/2003
3	EnzymesIBA 06/2022 - 03/2012
3	ImmunosorbentsIBA 06/2022 - 03/2012
3	Antinuclear AntibodiesIBA 01/2022 - 08/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
3	Antiphospholipid AntibodiesIBA 01/2018 - 01/2016
3	Complement System Proteins (Complement)IBA 01/2018 - 11/2006
3	LigandsIBA 11/2017 - 02/2010
3	CreatinineIBA 06/2017 - 01/2009
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2015 - 11/2011
3	Plasminogen Activators (Plasminogen Activator)IBA 08/2015 - 11/2011
3	AutoantigensIBA 05/2015 - 01/2002
3	Biological ProductsIBA 10/2014 - 08/2004
3	Endothelial Protein C ReceptorIBA 03/2012 - 07/2005
3	Peptides (Polypeptides)IBA 03/2009 - 08/2005
2	Interferon Type IIBA 01/2022 - 02/2008
2	Antimalarials (Antimalarial Agents)IBA 10/2020 - 02/2016
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 02/2010
2	Estrogens (Estrogen)FDA Link 01/2020 - 06/2005
2	Fluorinated SteroidsIBA 09/2017 - 01/2016
2	Toll-Like Receptor 7IBA 02/2016 - 03/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 05/2005
2	EpitopesIBA 05/2015 - 06/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2014 - 04/2010
2	anti-dsDNA autoantibodyIBA 12/2012 - 11/2006
2	Prednisone (Sone)FDA LinkGeneric 04/2010 - 11/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2010 - 12/2005
2	Oral ContraceptivesIBA 12/2005 - 04/2002
2	Anticardiolipin AntibodiesIBA 12/2005 - 06/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2005 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004 - 09/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2021
1	Immunoglobulin A (IgA)IBA 07/2021
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	baricitinibIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2019
1	Sialic Acid Binding Ig-like Lectin 1IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Malondialdehyde (Propanedial)IBA 01/2018
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	Cystatin CIBA 01/2018

Therapy/Procedure

12	Therapeutics 10/2020 - 09/2004
2	Ligation 02/2016 - 02/2010
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2005 - 04/2002
1	Secondary Prevention 01/2020
1	Immunomodulation 01/2020